BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 26185425)

  • 1. Patient satisfaction with the BETACONNECT™ autoinjector for interferon beta-1b.
    Weller I; Saake A; Schreiner T; Vogelreuter J; Petroff N
    Patient Prefer Adherence; 2015; 9():951-9. PubMed ID: 26185425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survey of US Patients with Multiple Sclerosis: Comparison of the New Electronic Interferon Beta-1b Autoinjector (BETACONNECT™) With Mechanical Autoinjectors.
    Barone DA; Singer BA; Merkov L; Rametta M; Suarez G
    Neurol Ther; 2016 Dec; 5(2):155-167. PubMed ID: 27277705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient Satisfaction with the New Interferon Beta-1b Autoinjector (BETACONNECT™).
    Ziemssen T; Sylvester L; Rametta M; Ross AP
    Neurol Ther; 2015 Dec; 4(2):125-36. PubMed ID: 26662362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoinjectors for administration of interferon beta-1b in multiple sclerosis: patient preferences and the ExtaviPro™ 30G and Betacomfort
    Thakur K; Manuel L; Tomlinson M
    Pragmat Obs Res; 2013; 4():19-26. PubMed ID: 27774021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The BETACONNECT™ system: MS therapy goes digital.
    Limmroth V; Bartzokis I; Bonmann E; Kusel P; Schreiner T; Schürks M
    Neurodegener Dis Manag; 2018 Dec; 8(6):399-410. PubMed ID: 30278827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of betaplus program on patient treatment satisfaction with interferon beta-1b in multiple sclerosis: Multicentric cross-sectional survey in the western Balkan countries.
    Drulovic J; Cukic M; Grgic S; Dincic E; Raicevic R; Nadj C; Toncev G; Vojinovic S; Mesaros S; Kisic Tepavcevic D; Dujmovic I; Tadic D; Miletic-Drakulic S; Dackovic J; Kostic S; Erakovic J; Sakalas L; Savic D; Suknjaja V; Martinovic V; Maric G; Pekmezovic T
    Mult Scler Relat Disord; 2017 Jan; 11():56-61. PubMed ID: 28104258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Reduction of injection site reactions in multiple sclerosis (MS) patients newly started on interferon beta 1b therapy with two different devices].
    Brochet B; Lemaire G; Beddiaf A;
    Rev Neurol (Paris); 2006 Jun; 162(6-7):735-40. PubMed ID: 16840982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adherence, satisfaction and functional health status among patients with multiple sclerosis using the BETACONNECT® autoinjector: a prospective observational cohort study.
    Kleiter I; Lang M; Jeske J; Norenberg C; Stollfuß B; Schürks M
    BMC Neurol; 2017 Sep; 17(1):174. PubMed ID: 28877664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient satisfaction with ExtaviPro™ 30G, a new auto-injector for administering interferon β-1b in multiple sclerosis: results from a real-world, observational EXCHANGE study.
    Hoffmann FA; Trenova A; Llaneza MA; Fischer J; Lus G; von Bredow D; Lara N; Lam E; Van Hoef M; Bakshi R
    BMC Neurol; 2017 Aug; 17(1):156. PubMed ID: 28793876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoinjector preference among patients with multiple sclerosis: results from a national survey.
    Limmroth V; Reischl J; Mann B; Morosov X; Kokoschka A; Weller I; Schreiner T
    Patient Prefer Adherence; 2017; 11():1325-1334. PubMed ID: 28831243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of Adherence Among Patients With Multiple Sclerosis Using the BETACONNECT
    Köhler W; Bayer-Gersmann K; Neußer T; Schürks M; Ziemssen T
    Front Neurol; 2021; 12():643126. PubMed ID: 33716945
    [No Abstract]   [Full Text] [Related]  

  • 12. Assessment of Medication Adherence Using a Medical App Among Patients With Multiple Sclerosis Treated With Interferon Beta-1b: Pilot Digital Observational Study (PROmyBETAapp).
    Limmroth V; Hechenbichler K; Müller C; Schürks M
    J Med Internet Res; 2019 Jul; 21(7):e14373. PubMed ID: 31359863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient-rated ease of use and functional reliability of an electronic autoinjector for self-injection of subcutaneous interferon beta-1a for relapsing multiple sclerosis.
    Singer B; Wray S; Miller T; Cascione M; Gupta A; Pardo G; Watsky E; Hayward B; Mercer B; Dangond F
    Mult Scler Relat Disord; 2012 Apr; 1(2):87-94. PubMed ID: 25876936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preferences and Perspectives of Specialist Multiple Sclerosis Nurses and Patients with Multiple Sclerosis Regarding the New RebiSmart
    Colten SS; di Cantogno EV; Jack D
    Med Devices (Auckl); 2024; 17():59-71. PubMed ID: 38404632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BetaEval Global: Prospective, Multinational, Observational Cohort Study of Patients Using BETACONNECT
    Patti F; Martínez Ginés ML; Norenberg C; Duarte Caron F
    Patient Prefer Adherence; 2020; 14():771-779. PubMed ID: 32425509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Results from the single-use autoinjector for self-administration of subcutaneous interferon beta-1a in patients with relapsing multiple sclerosis (MOSAIC) study.
    Wray S; Armstrong R; Herrman C; Calkwood J; Cascione M; Watsky E; Hayward B; Mercer B; Dangond F
    Expert Opin Drug Deliv; 2011 Dec; 8(12):1543-53. PubMed ID: 22032264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ascertaining Medication Use and Patient-Reported Outcomes via an App and Exploring Gamification in Patients With Multiple Sclerosis Treated With Interferon β-1b: Observational Study.
    Limmroth V; Bayer-Gersmann K; Mueller C; Schürks M
    JMIR Form Res; 2022 Mar; 6(3):e31972. PubMed ID: 35285806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evolution of the RebiSmart
    Lin YT; Will T; Wickham C; Boeree P; Jack D; Keiser M
    Patient Prefer Adherence; 2023; 17():1923-1933. PubMed ID: 37581193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ExtaviJect® 30G device for subcutaneous self-injection of interferon beta-1b for multiple sclerosis: a prospective European study.
    Boeru G; Milanov I; De Robertis F; Kozubski W; Lang M; Rojas-Farreras S; Tomlinson M
    Med Devices (Auckl); 2013; 6():175-84. PubMed ID: 24255602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Prospective, Observational, Multicenter Study Assessing Adherence to Interferon Beta-1b Therapy and Patient Satisfaction Using the BETACONNECT Auto-Injector.
    Farej R; Rametta M; La Rose A; Quillen A; McLeod K
    Neurol Ther; 2022 Mar; 11(1):373-384. PubMed ID: 35064907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.